Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators

被引:75
作者
Arao, Yukitomo [1 ]
Hamilton, Katherine J. [1 ]
Ray, Manas K.
Scott, Gregory
Mishina, Yuji [2 ]
Korach, Kenneth S. [1 ]
机构
[1] NIEHS, Receptor Biol Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA
[2] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA
关键词
BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENTS; PROVIDES EVIDENCE; NULL MICE; ER-ALPHA; IN-VIVO; BINDING; IDENTIFICATION; ANTIESTROGEN;
D O I
10.1073/pnas.1109180108
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The estrogen receptor (ER) is a ligand-dependent transcription factor containing two transcriptional activation domains. AF-1 is in the N terminus of the receptor protein and AF-2 activity is dependent on helix 12 of the C-terminal ligand-binding domain. Two point mutations of leucines 543 and 544 to alanines (L543A, L544A) in helix 12 minimized estrogen-dependent transcriptional activation and reversed the activity of the estrogen antagonists ICI182780 (ICI) and tamoxifen (TAM) into agonists in a similar manner that TAM activated WT ER alpha through AF-1 activation. To evaluate the physiological role of AF-1 and AF-2 for the tissue-selective function of TAM, we generated an AF-2-mutated ER alpha knock-in (AF2ERKI) mouse model. AF2ERKI homozygote female mice have hypoplastic uterine tissue and rudimentary mammary glands similar to ER alpha-KO mice. Female mice were infertile as a result of anovulation from hemorrhagic cystic ovaries and elevated serum LH and E2 levels, although the mutant ER alpha protein is expressed in the AF2ERKI model. The AF2ERKI phenotype suggests that AF-1 is not activated independently, even with high serum E2 levels. ICI and TAM induced uterotropic and ER-mediated gene responses in ovariectomized AF2ERKI female mice in the same manner as in TAM- and E2-treated WT mice. In contrast, ICI and TAM did not act as agonists to regulate negative feedback of serum LH or stimulate pituitary prolactin gene expression in a different manner than TAM- or E2-treated WT mice. The functionality of the mutant ER alpha in the pituitary appears to be different from that in the uterus, indicating that ER alpha uses AF-1 differently in the uterus and the pituitary for TAM action.
引用
收藏
页码:14986 / 14991
页数:6
相关论文
共 34 条
[1]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[2]   Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone [J].
Borjesson, A. E. ;
Windahl, S. H. ;
Lagerquist, M. K. ;
Engdahl, C. ;
Frenkel, B. ;
Moverare-Skrtic, S. ;
Sjogren, K. ;
Kindblom, J. M. ;
Stubelius, A. ;
Islander, U. ;
Antal, M. C. ;
Krust, A. ;
Chambon, P. ;
Ohlsson, C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (15) :6288-6293
[3]   Genome-wide identification of high-affinity estrogen response elements in human and mouse [J].
Bourdeau, V ;
Deschênes, J ;
Métivier, R ;
Nagai, Y ;
Nguyen, D ;
Bretschneider, N ;
Gannon, F ;
White, JH ;
Mader, S .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (06) :1411-1427
[4]  
BRZOZOWSKI AM, 1997, NATURE, V389, pE758
[5]   Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ERα but not ERβ [J].
Couse, JF ;
Yates, MM ;
Walker, VR ;
Korach, KS .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (06) :1039-1053
[6]   Estrogen receptor null mice: What have we learned and where will they lead us? [J].
Couse, JF ;
Korach, KS .
ENDOCRINE REVIEWS, 1999, 20 (03) :358-417
[7]   IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS [J].
DANIELIAN, PS ;
WHITE, R ;
LEES, JA ;
PARKER, MG .
EMBO JOURNAL, 1992, 11 (03) :1025-1033
[8]   IDENTIFICATION OF RESIDUES IN THE ESTROGEN-RECEPTOR THAT CONFER DIFFERENTIAL SENSITIVITY TO ESTROGEN AND HYDROXYTAMOXIFEN [J].
DANIELIAN, PS ;
WHITE, R ;
HOARE, SA ;
FAWELL, SE ;
PARKER, MG .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (02) :232-240
[9]   ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER [J].
DAUVOIS, S ;
DANIELIAN, PS ;
WHITE, R ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4037-4041
[10]   THE MECHANISM OF ICI-164,384 ANTIESTROGENICITY INVOLVES RAPID LOSS OF ESTROGEN-RECEPTOR IN UTERINE TISSUE [J].
GIBSON, MK ;
NEMMERS, LA ;
BECKMAN, WC ;
DAVIS, VL ;
CURTIS, SW ;
KORACH, KS .
ENDOCRINOLOGY, 1991, 129 (04) :2000-2010